Anavex’s newest patent will be expected to remain in force at least until July 2039, not including any patent term extensions. It will expand and supplement the current ANAVEX®2-73 (blarcamesine) ...
There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.
A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the ...
New research from The Feinstein Institutes for Medical Research reveals that brain imaging can detect subtle abnormalities in ...
Yet despite decades of research, no treatment has been created that arrests Alzheimer’s cognitive deterioration, let alone reverses it. That dismal lack of progress is partly because of the infinite ...
Over time, the disease can also affect memory and lead to dementia. A similar condition called Lewy Body Dementia (LBD), ...
Hearing impairment has emerged as a potential risk factor for Parkinson’s disease, a progressive neurodegenerative disorder that primarily manifests with motor impairments like tremors, rigidity, and ...
Arctic therapeutics raises funding from EIC Fund, Kaldbakur, and Sanos Group to advance its dementia treatment, AT-001, and acne drug, AT-004. The company aims to transform the treatment landscape for ...
Aerobic Exercise (Cardio): Physical activities like walking, running, swimming and cycling boost oxygen levels in the brain, ...
STATEN ISLAND, N.Y. — A new study reports that older adults who regularly drink coffee have a lower risk of developing ...
The risk of developing dementia may be double what was previously thought. But there are things the U.S. can do to help fight ...